Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis
Gerasimos Konidaris, E. Paul, Andreas Kuznik, Sam Keeping, Chieh-I Chen, Medha Sasané, Yingxin Xu, Kokuvi Atsou, Dieter Ayers, Emily S. Ruiz, Nikhil I. Khushalani, Shannon Cope
Topics & Concepts
MedicineCost effectivenessCost-effectiveness analysisGefitinibOncologyInternal medicineEpidermal growth factor receptorCancerRisk analysis (engineering)Nonmelanoma Skin Cancer StudiesCutaneous Melanoma Detection and ManagementPsoriasis: Treatment and Pathogenesis